Key Populations Brief: Indigenous Peoples. Stop TB Partnership. (2017)

immage

The world’s 370 million indigenous peoples face a plethora of issues caused by displacement, dispossession, loss of livelihood, systematic racism and abuse, and lack of recognition (1–4). Further hindering an adequate response to these challenges, there is a pervasive lack of data about indigenous peoples concerning health and other key development indicators. Data that are available show a prevalence of extreme poverty and severe health disparities that include tuberculosis (TB).

 

Keywords: TB, health, diagnosis, treatment, data

 

 

Download Publication

Statement on the Use of Child-friendly Fixed-dose Combinations for the Treatment of TB in Children. WHO and UNICEF. (2017)

immage

The World Health Organization (WHO) and UNICEF has issued a joint statement, urging all National TB Programmes to replace the previously used medicines for children weighing less than 25 kg with the child-friendly dispersible TB fixed-dose combinations (FDCs) at the soonest possible time. WHO and UNICEF advise against continued usage of the old sub-optimally dosed FDCs or adult formulations (crushed tablets), which may lead to under or over-dosing, unfavourable treatment outcomes, and high likelihood of contributing to the development of drug resistance. 


Keywords: TB, treatment, children, drug resistance

 

Download Publication

Ethics Guidance for the Implementation of the TB Strategy. WHO. (2017)

immage

The World Health Organization End TB Strategy is fully aligned with the framework of the Sustainable Development Goals (SDGs). Both require due attention to equity, human rights and ethics. In fact, “protecting human rights, ethics and equity” is one of the four key principles of the WHO End TB Strategy. The SDG agenda itself is inspired by a simple motto: “Leave no one behind”. Ensuring that these essential principles guide the implementation of the End TB Strategy is a must, especially when tuberculosis (TB) is rampant among the most vulnerable and marginalized populations everywhere in the world.


Keywords: human rights, care and prevention, treatment, children, prisoners, migrants, health care

 

Download Publication

STAC Annual Report 2016. SAARC TB and HIV/AIDS Centre (STAC). (2017)

immage

The Annual Report of SAARC TB and HIV/AIDS Centre is being presented indicating the programmes, activities and achievements of the year 2016.
This is the Twenty-first consecutive comprehensive Annual Report of the SAARC TB and HIV/AIDS Centre (STAC). This report provides a summary of the activities carried out by the Centre for the year 2016 along with introduction, goals, objectives, vision, mission and achievements of the Centre.
STAC implemented almost all regular activities assigned for the period of January to December 2016. The National Managers of the NTPs and NACPs are highly appreciable for their kind support to implement the activities.


Keywords: HIV, AIDS, TB, programmes, activities 

 

Download Publication

Infographic Tuberculosis and HIV. UNAIDS. (2017)

immage

UNAIDS calls for the elimination of TB deaths among people living with HIV and for health systems to be strengthened and services integrated to allow for a more rapid scale-up of HIV and TB programming. Countries must expand HIV prevention and treatment programmes that include regular TB screening, preventive therapy and early treatment, since they are simple, affordable and effective programmes that prevent TB deaths.


Keywords: HIV, AIDS, TB, PLHIV, death, children

 

 

Download Infographic

SAARC Epidemiological Response in Tuberculosis 2016. SAARC Tuberculosis and HIV/AIDS Centre. (2017)

immage

This report is an excellent review of the current status and future plans for the control of TB in the SAARC Region. It includes information on burden of tuberculosis in the SAARC region, including incidence, mortality along with the MDR-TB, TB/HIV confection etc. It also covers the information of the year 2014 and has been prepared on the basis of information collected from member countries during the year 2015 and by reviewing other related documents.


Keywords: HIV/AIDS, TB, co-infection, treatment, drug-resistant

 

Download Publication

Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis. WHO. (2017)

immage

The report – “Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including Mycobacterium tuberculosis” – shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance. Most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions. The report found very few potential treatment options for those antibiotic-resistant infections identified by WHO as posing the greatest threat to health, including drug-resistant tuberculosis which kills around 250 000 people each year. In addition to multidrug-resistant tuberculosis, WHO has identified 12 classes of priority pathogens – some of them causing common infections such as pneumonia or urinary tract infections – that are increasingly resistant to existing antibiotics and urgently in need of new treatments.


Keywords: TB, treatment, drugs, antibiotics

 

Download Publication

Bending the Curve - Ending TB: Annual Report 2017. WHO, Regional Office for South-East Asia. (2017)

immage

This is the second SEAR TB Report as we take first steps into the post 2015 era of the SDGs. In 2015, there was an estimated 4.74 million incidence of TB in the SEA Region, including HIV+TB co-infection. The total number of new cases notified to National TB programmes in the Region were around 2.65 million in appear staggering despite a reasonably good performance. Three countries that are poised well to eliminating TB by 2030 are Maldives, Bhutan and Sri Lanka. Nepal too is doing well despite the twin challenges of its mountainous terrain and coping with a major natural disaster. Timor-Leste, though small in terms of absolute TB numbers, faces a major challenge in bringing down its incidence rate.


Keywords: HIV, TB, ART, drug resistant, treatment

 

Download Publication

Ministerial Meeting towards Ending TB in the South-East Asia Region, 15-16 March 2017, New Delhi, India. WHO, Regional Office for South-East Asia. (2017)

immage

The two-day ministerial meeting held in Delhi was essentially aimed at raising the pitch on TB and garnering political commitment to end TB by 2030. From the above perspective the meeting was a resounding success considering that nine of 11 SEA Region health ministers attended the meeting promising to end TB with renewed momentum. Two countries had high level government representation. One of the core agendas of the meeting was framing the 'Call for Action' declaration and endorsing it by Member States. The 'Call for Action' declaration was signed by all SEA Region countries in an exemplary show of unity to 'bend the curve' and end TB. 


Keywords: HIV, TB, drug-resistant, treatment, diagnosis

 

 

Download Publication

 

Regional Response Plan for TB-HIV 2017–2021. WHO, Regional Office for South-East Asia. (2017)

immage

The Global Plan provides an opportunity for greater alignment among efforts to fight both diseases. Taking inspiration from the UNAIDS target of providing treatment to 90% of people who know their HIV-positive status, the Global Plan calls for countries to find at least 90% of all people with TB in the population that require treatment (including those living with HIV) and place them on appropriate therapy (including TB treatment and preventive therapy for people living with HIV).


Keywords: TB-HIV, PLHIV, response, funding, treatment

 

Download Publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_May-AIDSreg2017.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Oct
11
Nov
14
Nov
20